PubRank

Mitchell B Max

Author PubWeight™ 59.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2004 5.87
2 Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003 3.80
3 GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 2006 3.38
4 Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006 2.75
5 Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain 2009 2.53
6 Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain 2007 2.47
7 Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain 2010 2.41
8 Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain 2006 2.23
9 A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain 2009 2.01
10 Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable. J Pain Symptom Manage 2006 1.99
11 Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials. Pain 2008 1.82
12 Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A 2010 1.79
13 Candidate gene studies of human pain mechanisms: methods for optimizing choice of polymorphisms and sample size. Anesthesiology 2004 1.78
14 Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial. Anesthesiology 2008 1.65
15 Reliable screening for a pain-protective haplotype in the GTP cyclohydrolase 1 gene (GCH1) through the use of 3 or fewer single nucleotide polymorphisms. Clin Chem 2007 1.64
16 Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet 2008 1.59
17 Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet 2006 1.50
18 Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain 2006 1.22
19 Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia. Anesthesiology 2006 1.12
20 Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 2002 1.12
21 Topiramate in chronic lumbar radicular pain. J Pain 2005 1.11
22 Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother 2005 1.07
23 Haplotype structure of the beta adrenergic receptor genes in US Caucasians and African Americans. Eur J Hum Genet 2005 1.02
24 Symptoms of distress as prospective predictors of pain-related sciatica treatment outcomes. Pain 2006 1.02
25 A randomized, double-blind, placebo-controlled comparison of the analgesic efficacy, onset of action, and tolerability of ibuprofen arginate and ibuprofen in postoperative dental pain. Clin Ther 2002 1.00
26 Does the pain-protective GTP cyclohydrolase haplotype significantly alter the pattern or severity of pain in humans with chronic pancreatitis? Mol Pain 2008 0.95
27 Effects of chronic osteoarthritis pain on neuroendocrine function in men. J Clin Endocrinol Metab 2006 0.90
28 Clarifying the definition of neuropathic pain. Pain 2002 0.86
29 Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene. J Hum Genet 2004 0.85
30 Assessing pain candidate gene studies. Pain 2004 0.83
31 Stability and reliability of detection thresholds for human A-Beta and A-delta sensory afferents determined by cutaneous electrical stimulation. J Pain Symptom Manage 2003 0.83
32 Do motor control genes contribute to interindividual variability in decreased movement in patients with pain? Mol Pain 2007 0.83
33 Linkage of large-vessel carotid atherosclerotic stroke to inflammatory genes via a systematic screen. Int J Stroke 2010 0.82
34 Clinical evaluation of patients with temporomandibular joint implants. J Oral Maxillofac Surg 2002 0.80
35 Pain in Parkinson disease. Neurology 2004 0.79
36 Haplotype architecture of the norepinephrine transporter gene SLC6A2 in four populations. J Hum Genet 2004 0.78
37 An old acquaintance: opioids in neuropathic pain. Neurology 2003 0.76
38 Addressing the decline in NIH pain research funding. J Pain 2008 0.75
39 Low intensity permanent magnets in the treatment of chronic lumbar radicular pain. J Pain Symptom Manage 2007 0.75